HOUSTON, May 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP ... primarily due to $0.6 million of increased compensation and benefits, including non-cash stock compensation expense, and prelaunch marketing to …
Following this IND approval, and as an additional step to prepare for marketing, we will now start the necessary preparations in order to keep an emergency stock of PLX-R18 on hand for use in such events. We were also cleared by …
Each of these rates a “D” (“sell”) or “F” overall (“strong sell”). Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures.
PLX closed Thursday's trading at 0.55, down 3.48%. In after-hours, the stock was up 11.71% to $0.64. ZELTIQ Aesthetics Inc.'s (ZLTQ) fat freezing method CoolSculpting has now received FDA clearance to address another body area - upper …
Avago expects the acquisition to add immediately to non-GAAP earnings per share and anticipates “driving the PLX business to a level consistent with Avago’s long term business model by the end of fiscal year 2015.” Avago’s stock is …
One stock that might be an intriguing choice for investors right now is Protalix BioTherapeutics, Inc. (PLX). This is because this security in the Healthcare industry space is seeing solid earnings estimate revision activity, and is in great …
San Jose-based Integrated Device Technology reached a deal on April 30 to purchase PLX Technology for cash and stock totaling $330 million — and the two companies have been trying to win Federal Trade Commission approval since then. …
This is the second time in three months that a patient suffering from bone marrow failure was successfully treated with its PLX cells, the Israeli company ... failed bone marrow transplants, sending its stock up 32 percent.
New York, NY -- (SBWIRE) -- 07/25/2017 -- Proven efficacious as an antidote for Acute Radiation Syndrome (ARS) with data recently published from studies conducted by the U.S. National Institutes of Health (NIH), Pluristem Therapeutics' …
SBWire10mon